BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9625178)

  • 1. Diagnostic drift in the reporting of cancer incidence.
    Bailar JC
    J Natl Cancer Inst; 1998 Jun; 90(11):863-4. PubMed ID: 9625178
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for prostate cancer.
    Neal DE; Donovan JL
    Ann Oncol; 1998 Dec; 9(12):1289-92. PubMed ID: 9932157
    [No Abstract]   [Full Text] [Related]  

  • 3. PSA screening for prostate cancer: the current controversy.
    de Koning HJ; Schröder FH
    Ann Oncol; 1998 Dec; 9(12):1293-6. PubMed ID: 9932158
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prostatic intraepithelial neoplasia].
    Molinié V
    Ann Pathol; 2001 Jun; 21(3):245-54. PubMed ID: 11468562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A proposal on the identification, histologic reporting, and implications of intraductal prostatic carcinoma.
    Cohen RJ; Wheeler TM; Bonkhoff H; Rubin MA
    Arch Pathol Lab Med; 2007 Jul; 131(7):1103-9. PubMed ID: 17616999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic intraepithelial neoplasia is a risk factor for cancer.
    Bostwick DG
    Semin Urol Oncol; 1999 Nov; 17(4):187-98. PubMed ID: 10632120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraductal carcinoma of prostate: diagnostic criteria and differential diagnosis].
    Cheng L; Zhao M
    Zhonghua Bing Li Xue Za Zhi; 2014 Mar; 43(3):199-202. PubMed ID: 24842024
    [No Abstract]   [Full Text] [Related]  

  • 8. Intraductal Carcinoma of the Prostate: Morphologic Features, Differential Diagnoses, Significance, and Reporting Practices.
    Magers M; Kunju LP; Wu A
    Arch Pathol Lab Med; 2015 Oct; 139(10):1234-41. PubMed ID: 26414467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The sea of uncertainty surrounding ductal carcinoma in situ--the price of screening mammography.
    Welch HG; Woloshin S; Schwartz LM
    J Natl Cancer Inst; 2008 Feb; 100(4):228-9. PubMed ID: 18270336
    [No Abstract]   [Full Text] [Related]  

  • 10. The case for breast cancer screening in Singapore.
    Wee SB
    Singapore Med J; 2002 May; 43(5):221-3. PubMed ID: 12188070
    [No Abstract]   [Full Text] [Related]  

  • 11. Cancer Progress and Priorities: Prostate Cancer.
    Kensler KH; Rebbeck TR
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):267-277. PubMed ID: 32024765
    [No Abstract]   [Full Text] [Related]  

  • 12. Histopathological screening for prostate carcinoma: is a benign biopsy a negative biopsy?
    Sailer V; Kristiansen G
    APMIS; 2014 Aug; 122(8):690-8. PubMed ID: 25046199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence of impalpable carcinoma of the prostate and of non-malignant and precarcinomatous lesions in Greek male population: an autopsy study.
    Stamatiou K; Alevizos A; Agapitos E; Sofras F
    Prostate; 2006 Sep; 66(12):1319-28. PubMed ID: 16688747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PSA screening--current controversy.
    Svetec D; Thompson IM
    Ann Oncol; 1998 Dec; 9(12):1283-8. PubMed ID: 9932156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate pathology: histologic and molecular perspectives.
    Putzi MJ; De Marzo AM
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):407-21. PubMed ID: 11525288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of insignificant prostate cancer using free/total PSA: results of a case-finding protocol on 14,453 patients.
    Pepe P; Aragona F
    Prostate Cancer Prostatic Dis; 2010 Dec; 13(4):316-9. PubMed ID: 20714341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical aspects and treatment of "minimal" forms of breast cancer].
    Semiglazov VF; Orlov AA
    Vopr Onkol; 1983; 29(5):28-33. PubMed ID: 6305033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-simultaneous bilateral breast carcinoma.
    Watanatittan S; Ram MD
    Surgery; 1974 May; 75(5):740-5. PubMed ID: 4363178
    [No Abstract]   [Full Text] [Related]  

  • 19. Detection rates of cancer, high grade PIN and atypical lesions suspicious for cancer in the European Randomized Study of Screening for Prostate Cancer.
    Laurila M; van der Kwast T; Bubendorf L; di Lollo S; Pihl CG; Ciatto S; Hugosson J; Määttänen L; Roobol MJ; Kujala PM
    Eur J Cancer; 2010 Nov; 46(17):3068-72. PubMed ID: 21047588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-Specific Antigen: Nonspecific in Deceased Organ Donors.
    Pabisiak K; Ostrowski M; Kram A; Safranow K; Myślak M; Sieńko J; Sulikowski T; Ciechanowski K
    Transplant Proc; 2016 Jun; 48(5):1374-7. PubMed ID: 27496408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.